PubRank

Paolo Magni

Author PubWeight™ 50.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res 2004 2.47
2 Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 2007 2.04
3 Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol 2011 1.56
4 Temporal data mining for the quality assessment of hemodialysis services. Artif Intell Med 2005 1.27
5 Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1. Cell Metab 2011 1.10
6 Characterization of a synthetic bacterial self-destruction device for programmed cell death and for recombinant proteins release. J Biol Eng 2011 1.02
7 The use of benthic indicators in Europe: from the Water Framework Directive to the Marine Strategy Framework Directive. Mar Pollut Bull 2010 1.01
8 Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr 2008 1.01
9 Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer. Cancer Res 2008 1.01
10 Characterization of an inducible promoter in different DNA copy number conditions. BMC Bioinformatics 2012 1.01
11 The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol 2012 1.00
12 A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays. BMC Bioinformatics 2006 0.98
13 Bottom-up engineering of biological systems through standard bricks: a modularity study on basic parts and devices. PLoS One 2012 0.98
14 Dietary iron overload induces visceral adipose tissue insulin resistance. Am J Pathol 2013 0.96
15 Pharmacokinetics of orally administered melatonin in critically ill patients. J Pineal Res 2010 0.95
16 Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells. Endocrinology 2005 0.95
17 Modeling of human tumor xenografts and dose rationale in oncology. Drug Discov Today Technol 2013 0.91
18 TA-clustering: cluster analysis of gene expression profiles through Temporal Abstractions. Int J Med Inform 2005 0.90
19 A standard vector for the chromosomal integration and characterization of BioBrick™ parts in Escherichia coli. J Biol Eng 2013 0.89
20 Minimal model S(I)=0 problem in NIDDM subjects: nonzero Bayesian estimates with credible confidence intervals. Am J Physiol Endocrinol Metab 2002 0.89
21 Multiplexing and demultiplexing logic functions for computing signal processing tasks in synthetic biology. Biotechnol J 2011 0.87
22 The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways. Cancer Lett 2009 0.86
23 Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts. Cancer Chemother Pharmacol 2013 0.86
24 Modulatory actions of neuropeptide Y on prostate cancer growth: role of MAP kinase/ERK 1/2 activation. Adv Exp Med Biol 2007 0.86
25 The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells. Eur J Pharmacol 2010 0.86
26 Precedence Temporal Networks to represent temporal relationships in gene expression data. J Biomed Inform 2007 0.86
27 The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. BMC Evol Biol 2011 0.84
28 A Perl procedure for protein identification by Peptide Mass Fingerprinting. BMC Bioinformatics 2009 0.83
29 GC-MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect. Int J Pharm 2012 0.82
30 Random walk models for bayesian clustering of gene expression profiles. Appl Bioinformatics 2005 0.82
31 Comprehensive two-dimensional gas chromatography using large sample volume injection for the determination of polynuclear aromatic hydrocarbons in complex matrices. J Chromatogr A 2003 0.82
32 A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination. Cancer Chemother Pharmacol 2013 0.82
33 Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects. Br J Nutr 2012 0.81
34 Mouse embryonic stem cells that survive γ-rays exposure maintain pluripotent differentiation potential and genome stability. J Cell Physiol 2012 0.81
35 Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response. Ther Drug Monit 2002 0.81
36 A model-based approach to the in vitro evaluation of anticancer activity. Cancer Chemother Pharmacol 2008 0.81
37 Metabolic syndrome, adipokines and hormonal factors in pharmacologically untreated adult elderly subjects from the Brisighella Heart Study historical cohort. Obes Facts 2012 0.80
38 Adipokine actions on cartilage homeostasis. Adv Clin Chem 2011 0.80
39 On the myths of indicator species: issues and further consideration in the use of static concepts for ecological applications. PLoS One 2013 0.80
40 Inferring gene regulatory networks by integrating static and dynamic data. Int J Med Inform 2007 0.80
41 Modelling the effects of cell-to-cell variability on the output of interconnected gene networks in bacterial populations. BMC Syst Biol 2015 0.80
42 Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway. Neuro Endocrinol Lett 2006 0.80
43 Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients. Muscle Nerve 2012 0.80
44 Adiponectin interactions in bone and cartilage biology and disease. Vitam Horm 2012 0.80
45 Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer. Peptides 2007 0.79
46 Accurate peak list extraction from proteomic mass spectra for identification and profiling studies. BMC Bioinformatics 2010 0.79
47 TGI-Simulator: a visual tool to support the preclinical phase of the drug discovery process by assessing in silico the effect of an anticancer drug. Comput Methods Programs Biomed 2011 0.79
48 Integrating model-based decision support in a multi-modal reasoning system for managing type 1 diabetic patients. Artif Intell Med 2003 0.78
49 In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time. Cancer Chemother Pharmacol 2003 0.78
50 Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the brisighella heart study. Int J Endocrinol 2011 0.78
51 Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients. Aging Male 2013 0.77
52 Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases. Clin Chem Lab Med 2016 0.77
53 BDNF Serum Levels with Respect to Multidimensional Assessment in Amyotrophic Lateral Sclerosis. Neurodegener Dis 2016 0.76
54 Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance. Eur J Clin Invest 2014 0.76
55 Cholinergic regulation of neuropeptide Y synthesis and release in human neuroblastoma cells. Peptides 2007 0.76
56 Regulation of prostate cancer cell proliferation by somatostatin receptor activation. Mol Cell Endocrinol 2009 0.75
57 Antiproliferative activity on human prostate carcinoma cell lines of new peptidomimetics containing the spiroazepinoindolinone scaffold. Bioorg Med Chem 2013 0.75
58 Total, free and bound leptin and thyroid function in elderly women with different body weights. Clin Endocrinol (Oxf) 2007 0.75
59 Methods for genetic optimization of biocatalysts for biofuel production from dairy waste through synthetic biology. Conf Proc IEEE Eng Med Biol Soc 2015 0.75
60 Inferring gene expression networks via static and dynamic data integration. Stud Health Technol Inform 2006 0.75
61 Changes in stress hormones and metabolism during a 105-day simulated Mars mission. Aviat Space Environ Med 2014 0.75
62 Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor. Bioconjug Chem 2016 0.75